Amgen has created these resources as a comprehensive overview on the fundamentals of biosimilars and their impact on healthcare. Discover more on the pages linked below.
Promising opportunities for healthcare stakeholders
How a biosimilar gains a US Food and Drug Administration (FDA) interchangeability designation
Policies and purpose of maintaining consistency
Key differences in size, structure and manufacturing
How manufacturing parameters ensure biosimilarity
Why it's important to distinguish between the two